BMYD tahvilleri
Aşağıda BRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USD şirket tahvillerinin listesi bulunmaktadır. Yatırımcılar genellikle piyasa dalgalanması zamanlarında artan istikrarları için bir şirketin tahvillerini tercih ederler. Fiyatları, getirileri ve diğer istatistikleri inceleyin ve güvenilir bir yatırım bulun.
Sembol | Vade sonu getirisi % | Hacim | Fiyat % | Kupon % | Vade Tarihi | Ödenmemiş tutar | Nominal değer | Asgari brm tutarı | İhraççı |
---|---|---|---|---|---|---|---|---|---|
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | 7,52% | 30 K | 82,51% | 5,25% | 2043-08-15 | 4,06 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
7,36% | 0 | 57,47% | 2,55% | 2050-11-13 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | 7,21% | 10 K | 75,50% | 4,35% | 2047-11-15 | 13,57 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | 6,83% | 40 K | 84,51% | 5,00% | 2045-08-15 | 15,71 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | 6,81% | 100 K | 81,99% | 4,63% | 2044-05-15 | 3,69 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
6,68% | 0 | 70,44% | 3,90% | 2062-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,64% | 0 | 71,74% | 3,70% | 2052-03-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | 6,59% | 10 K | 93,18% | 5,70% | 2040-10-15 | 2,3 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
6,56% | 0 | 67,84% | 2,35% | 2040-11-13 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,34% | 4,53 M | 79,99% | 4,25% | 2049-10-26 | 3,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,34% | 30 K | 74,69% | 3,25% | 2042-08-01 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,25% | 2,48 M | 82,26% | 4,35% | 2047-11-15 | 1,24 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,24% | 0 | 78,02% | 3,55% | 2042-03-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,20% | 0 | 85,33% | 4,50% | 2044-03-01 | 341,52 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | 6,19% | 20 K | 84,30% | 4,55% | 2048-02-20 | 37,2 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
6,15% | 26 K | 84,90% | 4,55% | 2048-02-20 | 1,24 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,13% | 60 K | 99,85% | 3,88% | 2025-08-15 | 228,73 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,02% | 0 | 95,68% | 5,65% | 2064-02-22 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
6,00% | 846 K | 87,81% | 4,63% | 2044-05-15 | 744,72 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,92% | 0 | 96,02% | 5,55% | 2054-02-22 | 2,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,92% | 15 K | 113,00% | 6,88% | 2097-08-01 | 62,42 M USD | 1.000,00 USD | 1.000,00 USD | Bristol Myers Squibb Co. | |
5,91% | 150 K | 91,63% | 5,00% | 2045-08-15 | 741,72 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,86% | 0 | 106,34% | 6,40% | 2063-11-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,75% | 0 | 97,71% | 5,50% | 2044-02-22 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,73% | 0 | 105,58% | 6,25% | 2053-11-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,65% | 537 K | 88,12% | 4,13% | 2039-06-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,41% | 15 K | 105,41% | 6,13% | 2038-05-01 | 219,25 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,40% | 34 K | 98,58% | 5,25% | 2043-08-15 | 218,37 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,34% | 156 K | 103,04% | 5,70% | 2040-10-15 | 151,01 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
5,08% | 100 K | 105,74% | 5,88% | 2036-11-15 | 279,22 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,92% | 0 | 101,69% | 5,20% | 2034-02-22 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,90% | 0 | 90,21% | 2,95% | 2032-03-15 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | 4,88% | 36 K | 97,75% | 3,90% | 2028-02-20 | 43,84 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
4,77% | 0 | 106,70% | 5,90% | 2033-11-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,76% | 210 K | 85,96% | 1,45% | 2030-11-13 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,60% | 750 K | 95,71% | 3,40% | 2029-07-26 | 26,56 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,58% | 0 | 100,21% | 4,95% | 2026-02-20 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,46% | 63 K | 98,88% | 0,75% | 2025-11-13 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,46% | 2,5 M | 100,20% | 4,82% | 2026-02-20 | 500 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,42% | 0 | 98,25% | 3,25% | 2027-02-27 | 512,28 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,42% | 0 | 103,04% | 5,10% | 2031-02-22 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,39% | 522 K | 96,62% | 3,40% | 2029-07-26 | 2,37 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,38% | 0 | 106,09% | 5,75% | 2031-02-01 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | 4,37% | 20 K | 98,05% | 3,45% | 2027-11-15 | 16,55 M USD | 1.000,00 USD | 2.000,00 USD | Celgene Corp. |
4,32% | 3 K | 99,04% | 3,20% | 2026-06-15 | 1,74 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,31% | 20 K | 103,10% | 6,80% | 2026-11-15 | 255,95 M USD | 1.000,00 USD | 1.000,00 USD | Bristol Myers Squibb Co. | |
4,26% | 0 | 101,98% | 4,90% | 2029-02-22 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,21% | 0 | 101,03% | 4,90% | 2027-02-22 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,19% | 5,06 M | 99,32% | 3,90% | 2028-02-20 | 1,45 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,18% | 0 | 93,58% | 1,13% | 2027-11-13 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
4,07% | 5 K | 98,69% | 3,45% | 2027-11-15 | 517,67 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
3,61% | 0 | 86,51% | 1,75% | 2035-05-15 | 575 M EUR | 1.000,00 EUR | 100.000,00 EUR | Bristol Myers Squibb Co. | |
2,47% | 0 | 130,24% | 4,25% | 2049-10-26 | 500 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,39% | 0 | 122,76% | 4,13% | 2039-06-15 | 4,4 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,35% | 0 | 141,76% | 5,00% | 2045-08-15 | 1 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,32% | 0 | 137,60% | 4,55% | 2048-02-20 | 9,5 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
2,27% | 0 | 104,25% | 3,20% | 2026-06-15 | 5,95 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
1,47% | 0 | 116,80% | 3,90% | 2028-02-20 | 6,07 M USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. | |
1,28% | 0 | 114,77% | 3,45% | 2027-11-15 | 67 K USD | 1.000,00 USD | 2.000,00 USD | Bristol Myers Squibb Co. |